We investigated and compared the toxicity profile, as well as possible neuroprotective effects, of some antiepileptic drugs in cultured Ž . Ž . w x rat hippocampal neurons. We used two novel carbamazepine derivatives, S -y -10-acetoxy-10,11-dihydro-5H-dibenz b,f azepine-5-Ž . w x Ž . carboxamide BIA 2-093 and 10,11-dihydro-10-hydroxyimino-5H-dibenz b,f azepine-5-carboxamide BIA 2-024 , and compared their effects with the established compounds carbamazepine and oxcarbazepine. The assessment of neuronal injury was made by using the Ž . Ž . 3-4,5-dimethylthiazol-2-yl -2,5-diphenyl MTT assay, as well as by analysing morphology and nuclear chromatin condensation Ž . propidium iodide staining , after hippocampal neurons were exposed to the drugs for 24 h. The putative antiepileptic drugs, BIA 2-093 or Ž . BIA 2-024 at 300 mM , only slightly decreased MTT reduction, whereas carbamazepine or oxcarbazepine were much more toxic at lower concentrations. Treatment with the antiepileptic drugs caused nuclear chromatin condensation in some neurons, which is characteristic of apoptosis, and increased the activity of caspase-3-like enzymes, mainly in neurons treated with carbamazepine and Ž . oxcarbazepine. The toxic effect caused by carbamazepine was not mediated by N-methyl-D-aspartate NMDA or by a-amino-3-hydroxy-Ž . 5-methyl-isoxazole-4-propionate AMPA receptors. Moreover, the antiepileptic drugs failed to protect hippocampal neurons from the toxicity caused by kainate, veratridine, or ischaemia-like conditions. q
Introduction
Epilepsy is one of the most common neurological diseases, affecting at least 50 million people worldwide Ž . Scheuer and Pedley, 1990 . The major antiepileptic drugs in clinical use, i.e. phenytoin, carbamazepine, valproate and phenobarbital, among others, were developed and introduced between 1910 and 1970, and are referred to as Afirst-generationB drugs. Several new anticonvulsant drugs, such as vigabatrin, gabapentin, felbamate, lamotrigine and oxcarbazepine, have been introduced into clinical practice and are referred to as Asecond-generationB drugs. More recent anticonvulsants, which are in preclinical or clinical development, can be considered as Athird-generationB drugs Ž . Loscher, 1998a . Carbamazepine has become the most frequently prescribed first-line drug for the treatment of partial and Ž generalised tonic-clonic epileptic seizures Loiseau and . Duche, 1995 . Moreover, carbamazepine has been used iń the treatment of neuropathic pain and schizoaffective psychosis. However, patients treated with carbamazepine may develop toxic symptoms, such as drowsiness, dizziness, ataxia and nausea. Other disadvantages of carbamazepine Ž . are its enzyme-inducing properties Tateishi et al., 1999 Ž . and interaction with other drugs Yasui et al., 1997 , as well as the increase in the incidence of congenital malfor-Ž . mations Kaneko et al., 1999 . Although most of the toxic symptoms of carbamazepine are in the central nervous Ž . system CNS , the mechanisms by which this antiepileptic 0014-2999r00r$ -see front matter q 2000 Elsevier Science B.V. All rights reserved.
Ž . PII: S 0 0 1 4 -2 9 9 9 0 0 0 0 6 5 9 -2 ( )drug causes toxicity are not completely clarified. Some reports indicate that carbamazepine induces apoptosis in Ž cultured cerebellar granule cells Gao and Chuang, 1992;  . Nonaka et al., 1998 and decreases glutamine synthetase Ž . activity Fraser et al., 1999 . Conversely, it was previously shown that carbamazepine exerted protective effects against Ž focal ischaemia or anoxia Fern et al., 1993; Rataud et al., . 1994; Minato et al., 1997 , or against toxicity induced by Ž glutamate or veratridine Mattson and Kater, 1989; Lakics . et al., 1995; Mark et al., 1995 . In addition, carbamazepine did not prevent status epilepticus-induced damage to neu-Ž . rons in hippocampus and amygdala Pitkanen et al., 1996 . Oxcarbazepine is an analogue of carbamazepine, with a comparable anticonvulsant efficacy. It has the advantage of a low incidence of allergic reactions and enzyme induction. In case of combination therapy with other antiepileptic drugs, oxcarbazepine is usually better tolerated than Ž . carbamazepine Elger and Bauer, 1998 . However, the involvement of oxcarbazepine in neuronal toxicity has not been investigated.
Since seizures are resistant to treatment with currently available antiepileptic drugs in about 30% of patients with epilepsy, more effective antiepileptic drugs are necessary. In addition, because of the inadequacy of the currently available antiepileptic drugs, in terms of safety, newly developed drugs should be less toxic than existing drugs. Ž . Ž . w x S -y -10-acetoxy-10,11-dihydro-5 H-dibenz b,f aze-Ž . pine-5-carboxamide BIA 2-093; Benes et al., 1999a and w x 10,11-dihydro-10-hydroxyimino-5 H-dibenz b,f azepine-Ž . 5-carboxamide BIA 2-024; Benes et al., 1999b are representative of new compounds, structurally related to carbamazepine and oxcarbazepine, with anticonvulsant activity, Ž as determined by maximal electroshock Benes et al., . 1999a,b . These two compounds were specifically designed to circumvent their further degradation to toxic metabolites, such as epoxides, without losing anticonvulsant potency. For example, BIA 2-093 produces significantly less motor and cognitive impairment than carba-Ž . mazepine and oxcarbazepine Benes et al., 1999a . In the Ž present work, we used an in vitro system cultured hip-. pocampal neurons , to investigate the toxic profile of BIA 2-093 and BIA 2-024, as well as their possible protective effects against several neurotoxic insults, in comparison with the antiepileptic drugs carbamazepine and oxcarbazepine.
Materials and methods

Cell culture
Hippocampal neurons were dissociated from hippocampi of E18-E19 Wistar rat embryos, after treatment Ž . with trypsin 1.0 mgrml; 15 min; 378C and deoxyribo-Ž . NaHCO , 5 mM glucose, supplemented with 0.001% phe-3 . nol red, 1 mM sodium pyruvate, 10 mM HEPES, pH 7.4 . Hippocampal neurons were cultured in B27-supplemented Ž . Neurobasal medium GIBCO , a serum-free medium com-Ž . bination Brewer et al., 1993 , supplemented with gluta-Ž . Ž . Ž mate 25 mM , glutamine 0.5 mM and gentamicin 0.12 . mgrml . Cultures were kept at 378C in a humidified incubator in 5% CO r95% air, for 7-8 days, the time 2 required for maturation of hippocampal neurons. Ž For the assessment of neuronal injury with the 3-4,5-. dimethylthiazol-2-yl -2,5-diphenyltetrazolium bromide Ž . MTT assay, or to measure the activity of caspase-3-like enzymes, hippocampal neurons were plated on poly-D-Ž . lysine-coated 0.1 mgrml multiwells at a density of 0.1 = 10 6 or 0.2 = 10 6 cellsrcm 2 , respectively. For morphology studies with Cresyl violet staining, or analysis of nuclear condensationrfragmentation with propidium iodide staining, cells were plated at a density of 45 = 10 3 cellsrcm 2 on poly-D-lysine-coated coverslips.
Exposure of hippocampal neurons to drugs
The hippocampal neurons were exposed to drugs for 24 h. The drugs were diluted in aliquots of 250 ml of conditioned medium, taken from each well and placed in an Eppendorf tube. Then, the aliquots were added back to the corresponding well, and the medium was mixed gently to preserve the integrity of neurons. The toxicity was assessed by using either the MTT assay, by analysing neuronal morphology, or by counting neurons with nuclear condensation andror fragmentation. The activity of caspase-3-like enzymes was also measured, as described in the next.
MTT assay
Assessment of neuronal injury in cultured hippocampal neurons was made by using the MTT assay. Briefly, Krebs Ž . buffer with MTT 0.5 mgrml was added to the cultures and incubated for 1 h at 378C in the incubation chamber. MTT, when taken up by living cells, is converted from a yellow to a water-insoluble blue-coloured product. The precipitated dye was dissolved in 0.04 M HCl in iso-Ž . propanol and colorimetrically absorbance at 570 nm quantitated.
Morphology studies
After incubation of cultured hippocampal neurons with the drugs, for 24 h, the culture medium was removed, the cells were washed two times with phosphate-buffered saline ŽPBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na HPO , 1.8 2 4
. mM KH PO , pH 7.4 , and fixed with 0.1% glutaralde-2 4 ( )hyde in PBS at 378C. After 30 min, the cells were washed Ž . two times with PBS 10 min each time and then dehy-Ž drated in a gradient of ethanolrPBS 50%, 70%, 80%, . 95% and 100% ethanol and ethanolracetone 1:1, about 1 min per solution. After this procedure, the cells were Ž rehydrated in a gradient of ethanolrPBS 100%, 95%, . 80%, 70% and 50% ethanol and then washed two times with PBS. The cells were stained with 0.5% Cresyl violet for 5 min, washed several times with ultrapurified water, and dried. Finally, the coverslips containing the cells were Ž . mounted with Entellan Merck , and micrographs were taken.
Propidium iodide staining
After incubation with the drugs, cells were fixed in 4% paraformaldehyde and then stained with propidium iodide Ž . 1.3 mgrml in Krebs medium. Apoptotic neurons, with condensedrfragmented nuclei, were counted by using a Ž fluorescence microscope and a triple filter Omega Optical . XF63 . The neuronal counting was done by counting approximately 200 neurons in about 10 fields in each coverslip.
Caspase-3-like actiÕity assay
After the exposure of hippocampal neurons to drugs for 24 h, the culture medium was aspirated, and the cultures were washed two times with the following buffer: 50 mM KCl, 50 mM PIPES, 10 mM EGTA and 2 mM MgCl , pH 2 7.4, at 48C. The cells were again washed with the washing buffer supplemented with 100 mM phenyl-methyl-sulfonyl-fluoride, 1 mM dithiothreitol and 1 mgrml Chymo-Ž . statin-Leupeptin-Antiparin-Pepstatin A CLAP . After this procedure, cells were lysed at 48C with the previous supplemented buffer, with 0.5% Triton, collected and Ž . frozenrthawed at y808C three times . Protein concentration was determined, and 20 mg of protein was used for Ž . each determination. The extract 20 mg was added to 40 Ž wŽ ml of reaction buffer 25 mM HEPES, 0.1% 3-3-. x cholamidopropyl dimethylammonio -1-propane-sulfonate Ž . CHAPS , 10 mM dithiothreitol, 100 mM phenyl-methylsulfonyl-fluoride, pH 7.5, which was supplemented with 100 mM Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl Ž . coumarin DEVD-AFC , a fluorogenic substrate for cas-. pase-3 and related proteases and incubated for 30 min, at 378C.
Ž .
Ž . Ž . 
Ž
After incubation, the fluorescence was monitored exci-. tation from 300 to 410 nm and emission 475 nm using a Spex Fluoromax spectrofluorometer. The results are ex-Ž . pressed as percentage of control no treatment , using arbitrary fluorescence units, at an excitation wavelength of 390 nm.
Ischemia-like conditions experiments
Hippocampal neurons were exposed to Krebs medium Ž without glucose and supplemented with 2-deoxyglucose 5 . Ž . mM and sodium cyanide 2.5 mM , which inhibits cytochrome c oxidase, for 10 min. After this period, neurons were washed two times with Krebs medium with glucose and incubated with Neurobasal medium in an incubation chamber at 378C, for a 1-or 2-h recovery period. The antiepileptic drugs tested were present during the ischaemic period and during the recovery period. After this period, the metabolic activity was assessed by using the MTT assay.
Chemicals
BIA 2-093, BIA 2-024, carbamazepine and oxcarbazepine were obtained from BIAL, S. Mamede do Coronado, Ž . Ž . Portugal. y -1-4-Aminophenyl -4-methyl-7,8-methylenedioxy-4,5-dihydro-3-methylcarbamoyl-2,3-benzodi-Ž . azepine LY 303070 was a kind gift of Lilly Research Ž Laboratories, Indianapolis, IN, USA, and dizocilpine MK-. 801 was a kind gift of Merck Sharp and Dohme, NJ, USA. Neurobasal medium, B27 supplement, gentamicin Ž . and trypsin USP grade were purchased from GIBCO BRL, Life Technologies, Scotland. Glutamate, DNase Ž . DN-25 , veratridine, 2-deoxyglucose, sodium cyanide, phenyl-methyl-sulfonyl-fluoride, CLAP and dithiothreitol were purchased from Sigma, St. Louis, MO, USA. Kainate was purchased from TOCRIS, Bristol, UK. Glutaraldehyde and paraformaldehyde were obtained from MerckSchuchardt, Germany. Propidium iodide was purchased from Molecular Probes, Leiden, The Netherlands. All other reagents were from Sigma or from Merck-Schuchardt.
Ž .
Ž . 
Statistical analysis
The data are expressed as means " S.E.M. Statistical significance was determined by using an analysis of vari-Ž . ance ANOVA , followed by Dunnett's or Bonferroni's post-tests, as indicated in the figure legends.
Results
Effects of antiepileptic drugs on the Õiability of cultured rat hippocampal neurons
We investigated the effect of 24 h exposure of cultured hippocampal neurons to BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine. The presence of 300 mM BIA 2-093 for 24 h decreased the MTT reduction to 84.4 " 3.5% Ž . Ž P -0.05 , as compared to control no drug treatment;
. Ž Fig. 1A . Lower concentrations of BIA 2-093 50 and 100 . mM did not cause toxicity. In the presence of BIA 2-024 Ž . 300 mM the MTT reduction was 86.8 " 2.4% of the Ž . control P ) 0.05; Fig. 1B . Treatment of hippocampal neurons either with carbamazepine or with oxcarbazepine caused a neurotoxic effect at lower concentrations, as compared to BIA 2-093 or BIA 2-024. In the presence of 100 or 300 mM carbamazepine, the MTT reduction de-Ž . Ž creased to 82.8 " 5.3% P -0.05 or 75.4 " 2.3% P -. Ž . 0.01 of the control, respectively Fig. 1C . The toxic effect caused by oxcarbazepine was even higher. Thus, Fig. 3 . Quantification of apoptotic hippocampal neurons exposed to Ž . antiepileptic drugs for 24 h. The concentration in mM of BIA 2-093, Ž . Ž . BIA 2-024, carbamazepine CBZ or oxcarbazepine OXC is indicated below the corresponding bars. The results are presented as percentages of apoptotic neurons, and represent the means"S.E.M. of at least three independent experiments. ) P -0.05, ) ) P -0.01 -Significantly different from control; Dunnett's post-test. treatment of hippocampal neurons with 50, 100 or 300 mM oxcarbazepine for 24 h decreased the reduction of MTT to Ž . Ž . 86.6 " 3.9% P -0.05 , 65.9 " 4.2% P -0.01 or 62.5 Ž . " 3.2% of the control, respectively Fig. 1D . We also exposed hippocampal neurons to the antiepileptic drugs for Ž . shorter periods 1 h and measured metabolic activity 24 h later, in order to assess possible delayed neurotoxic effects, but the results indicated that the antiepileptic drugs were Ž . not toxic under these conditions not shown .
Morphological studies showed neuronal deterioration, mainly in hippocampal neurons exposed to high concentra-Ž . tions of carbamazepine or oxcarbazepine Fig. 2 . However, some morphological changes were also observed in neurons treated with high concentrations of either BIA 2-093 or BIA 2-024. In Fig. 2 , hippocampal neurons treated with BIA 2-024 are not shown since the morphological changes were similar to those of neurons treated with BIA 2-093. Some neurons showed nuclear condensation, indicative of apoptosis, and other neurons appeared to be disintegrated, suggesting necrotic-like cell death.
We also analysed nuclear condensationrfragmentation in cultured hippocampal neurons exposed to the antiepileptic drugs, by using propidium iodide, which stains nucleic acids in cells pre-fixed with paraformaldehyde. In control cultures, 13% of total neurons were apoptotic. In the presence of 100 or 300 mM BIA 2-093, the proportion of Ž . apoptotic neurons was 16 " 2% or 23 " 3% P -0.05 of Ž . total neurons, respectively Fig. 3 . Similar results were obtained with BIA 2-024: the proportion of apoptotic neurons in cultures treated with 100 or 300 mM BIA 2-024 was 15 " 2% or 22 " 1% of total neurons, respectively. The number of apoptotic neurons significantly increased in tions no drug treatment . P -0.05, P -0.01 -Significantly different from control; Dunnett's post-test.
the presence of either carbamazepine or oxcarbazepine. Thus, when hippocampal neurons were exposed to 100 or 300 mM carbamazepine the proportion of apoptotic neu-Ž . Ž . rons was 25 " 2% P -0.05 or 31 " 3% P -0.01 , Ž respectively. In the case of oxcarbazepine 100 or 300 . mM the proportion of apoptotic neurons was 27 " 1% Ž . Ž . P -0.01 or 39 " 3% P -0.01 of total neurons, re-Ž . spectively Fig. 3 . These results indicate that the antiepileptic drugs may cause apoptosis, at least at higher concentrations.
Effects of antiepileptic drugs on the actiÕity of caspase-3-like enzymes
We measured the activity of caspase-3 and related proteases in hippocampal neurons treated with antiepileptic drugs by using a fluorogenic substrate for these enzymes. The activity of caspase-3-like enzymes was higher in oxcarbazepine-treated neurons than in neurons treated with Ž . the other antiepileptic drugs Fig. 4 . The presence of BIA Ž . Ž . Fig. 6 . Lack of protective effect of BIA 2-093, BIA 2-024, carbamazepine CBZ or oxcarbazepine OXC on neuronal degeneration caused by exposure of Ž . hippocampal neurons to kainate KA; 100 mM for 24 h. The concentrations of the antiepileptic drugs are indicated below the bars. The results represent the means" S.E.M. of at least three independent experiments performed in triplicate, and are presented as percentages of MTT reduction under control Ž . ) ) conditions no drug treatment .
P -0.01 -Significantly different from control; Dunnett's post-test.
( )Ž . Ž . 2-024 300 mM or BIA 2-093 300 mM increased the activity of caspase-3-like enzymes to only 120.7 " 3.8% Ž . Ž . P ) 0.05 or 112.1 " 4.8% P ) 0.05 of the control, respectively. However, oxcarbazepine and carbamazepine caused a higher and significant increase, especially at high Ž concentrations. Thus, oxcarbazepine 50, 100 and 300 . mM increased the activity of caspase-3-like proteases to Ž . 115.4 " 7.9% P ) 0.05 , 145.8 " 9.8% and 283.9 " 5.6% of the control, respectively. In the case of carbamazepine Ž . 300 mM , the activity of caspase-3-like enzymes increased to 130.9 " 4.7% of the control, and no effect was observed at 100 mM.
( ) 3.3. Effects of N-methyl-D-aspartate NMDA or a-amino-( ) 3-hydroxy-5-methyl-isoxazole-4-propionate AMPA receptor antagonists on the toxicity caused by carbamazepine
We also checked whether NMDA or AMPA receptors are involved in the neurotoxic effect caused by carbamazepine. For this purpose, we treated hippocampal neu-Ž rons with a high concentration of carbamazepine 300 . Ž . mM in the presence of either MK-801 10 mM , a NMDA Ž . receptor antagonist, or LY 303070 15 mM , an AMPA receptor antagonist, and observed that these glutamate receptor antagonists did not protect neurons from the Ž . toxicity caused by carbamazepine Fig. 5 . Similar results Ž were obtained in neurons treated with oxcarbazepine not . shown , suggesting that NMDA and AMPA receptors are not involved in the toxicity caused by carbamazepine or oxcarbazepine.
Kainate-induced neurotoxicity in cultured hippocampal neurons: lack of protection by BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine
Non-NMDA receptor activation contributes to the epileptic phenomena and is also implicated in excitotoxicity. Thus, we investigated whether BIA 2-093, BIA 2-024, carbamazepine and oxcarbazepine act as neuroprotectors against the neurotoxic effect caused by kainate. Treatment of cultured hippocampal neurons with 100 mM kainate for 24 h decreased MTT reduction to 70.5 " 2.9% of the Ž . control Fig. 6 . As previously shown, this neurotoxic effect was mainly due to the activation of AMPA receptors Ž . Ž . Fig. 7 . Lack of protective effect of BIA 2-093, BIA 2-024, carbamazepine CBZ or oxcarbazepine OXC on neuronal degeneration caused by veratridine Ž . Ver; 30 mM . The results represent the means " S.E.M. of at least three independent experiments performed in triplicate, and are presented as percentages Ž . ) ) of MTT reduction under control conditions no drug .
P -0.01 -Significantly different from control; Dunnett's post-test. McLean et al., 1994; Kuo et al., 1997; Benes et . al., 1999a are known to block voltage-sensitive sodium channels. We investigated whether these antiepileptic drugs could protect hippocampal neurons against veratridine-induced toxicity. Veratridine caused a concentration-dependent neurotoxic effect. We observed that in hippocampal neurons treated for 24 h with 10, 30 or 50 mM veratridine Ž . the MTT reduction decreased to 85.6 " 1.8% P ) 0.05 , Ž . 68.9 " 3.5% P -0.01 or 49.7 " 2.3% of the control, respectively. In order to test the efficacy of the antiepileptic drugs in protecting hippocampal neurons, we chose the lowest concentration of veratridine that caused a significant neurotoxic effect: 30 mM. The results obtained show that the antiepileptic drugs, at concentrations below those that caused toxicity, did not protect hippocampal neurons Ž . from veratridine-induced toxicity Fig. 7 . 
Chemical ischaemia-induced toxicity: lack of protection by BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine
Some reports indicate that antiepileptic drugs may be Ž neuroprotective under ischaemic conditions Rataud et al., . 1994; Taylor, 1996 . We further investigated a possible neuroprotective role of BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine, by testing their effects in hippocampal neurons exposed to ischaemia-like conditions. Exposure of hippocampal neurons to both 5 mM 2-deoxyglucose and 2.5 mM sodium cyanide, for 10 min, decreased the MTT reduction to 49.0 " 3.7% of the con-Ž . trol Fig. 8A . After washing and a further 1-h incubation in Neurobasal medium, neurons partially recovered their metabolic activity, since the MTT reduction increased to Ž69.3 " 4.1% of the control P -0.01, as compared to . that after a 10-min exposure to deoxyglucose plus cyanide . However, 2 h after exposure to ischaemia-like conditions, an impairment of metabolic activity was observed, since Ž the MTT reduction was similar 54.2 " 3.3% of the con-. trol to that observed when neurons were treated with deoxyglucose and cyanide for 10 min, without a recovery period. Moreover, when neurons were treated with either deoxyglucose or cyanide, and left to recover for 2 h, the Ž . MTT reduction was 83.6 " 3.6% P -0.05 or 86.8 " Ž . Ž . 4.9% P ) 0.05 of the control, respectively Fig. 8A . Fig. 8 . A Evaluation of the metabolic activity of hippocampal neurons exposed to ischaemia-like conditions. Hippocampal neurons were treated Ž . Ž . with 5 mM 2-deoxyglucose DG andror 2.5 mM sodium cyanide CN for 10 min. As indicated below bars, in some cases neurons were left to recover for 1h or 2 h, respectively. The results represent the means" S.E.M. of at least three independent experiments performed in triplicate, and are presented as percentage of MTT reduction, compared to that
Ž .
under control conditions no drug . P -0.05, P -0.01 -Significantly different from control; Dunnett's post-test.
qq P -0.01 -Significantly different from chemical-ischaemia conditions; xx P -0.01 -Significantly different from chemical-ischaemia conditions plus 1 h recovery Ž . in Neurobasal medium; Bonferroni's post-test. B Lack of protective Ž . effect of BIA 2-093, BIA 2-024, carbamazepine CBZ or oxcarbazepine Ž . OXC against ischaemia-like conditions in cultured hippocampal neurons. In this particular case, ischaemic conditions were ischaemia-like conditions plus 2 h recovery in Neurobasal medium, in the absence of Ž antiepileptic drugs. In non-control conditions the antiepileptic drugs 300 . mM were present during both ischaemic and recovery periods. The results represent the means"S.E.M. of at least six independent experiments performed in triplicate, and are presented as percentage of MTT reduction, compared to that under ischaemic conditions.
We then investigated the effect of BIA 2-093, BIA Ž . 2-024, carbamazepine or oxcarbazepine at 300 mM on the metabolic activity of hippocampal neurons exposed to ischaemia-like conditions. The antiepileptic drugs were present when hippocampal neurons were exposed for 10 ( )min to both deoxyglucose and cyanide, as well as during the 2-h recovery period. We chose a concentration of the Ž . antiepileptic drugs 300 mM which was not toxic to hippocampal neurons after a 2-h exposure. The results show that the presence of the antiepileptic drugs did not protect hippocampal neurons from the toxic effect caused Ž . by ischaemia-like conditions Fig. 8B . 
Discussion
Neurotoxic effect caused by antiepileptic drugs in cultured hippocampal neurons
It is widely accepted that antiepileptic drugs may cause CNS side effects. For example, antiepileptic drug therapy can affect cognitive function in patients with epilepsy Ž . Delcker et al., 1997; Meador, 1998 . Conversely, it has been shown that some antiepileptic drugs have neuropro-Ž . tective effects Rataud et al., 1994; Minato et al., 1997 . In the present work, we used an in vitro preparation to investigate the neurotoxicrneuroprotective profile of two new anticonvulsants, BIA 2-093 and BIA 2-024, in comparison to the established compounds carbamazepine and oxcarbazepine.
We found that BIA 2-093 and BIA 2-024 were less toxic to hippocampal neurons than are the related compounds, carbamazepine and oxcarbazepine, based on the fact that carbamazepine and oxcarbazepine are more toxic at lower concentrations. Indeed, at the highest concentra-Ž . tion used 300 mM , BIA 2-024 did not cause a significant toxic effect, as assessed either by MTT assay or by propidium iodide staining. However, carbamazepine and oxcarbazepine were toxic, although at concentrations above those found in the CSF or plasma. For example, in humans, therapeutic serum levels of carbamazepine are 17-51 mM, and CSF levels may range from 17% to 31% of the Ž . plasma concentration Rogawski and Porter, 1990 . Moreover, in rats receiving four times the ED dose of carba-50 mazepine against maximal electroshock seizure, the peak brain extracellular fluid concentration is approximately 11 Ž . mM Dailey et al., 1997 . However, the concentrations used in the present work were not different from the Ž concentrations reported previously Stefani et al., 1995; Dailey et al., 1997; Nonaka et al., 1998; Benes et al., . 1999a; Lingamaneni and Hemmings, 1999 . The toxic effect observed at high concentrations may be relevant to some of the adverse syndromes associated with overdosage.
It is important to mention that the antiepileptic drugs studied are not metabolised by neuronal tissue in vitro Ž . unpublished observations , but are rapidly metabolised in vivo, giving origin to various metabolites, some of which Ž are also responsible for the effect of the drugs Rogawski . and Porter, 1990 ; unpublished observations . Thus, it is difficult to extrapolate these results to an in vivo situation.
However, these results may be useful to better understand the mechanism of action of antiepileptic drugs, or even to compare their neurotoxicrneuroprotective profile, since it is important to find new antiepileptic drugs with fewer CNS adverse effects.
Exposure of hippocampal neurons to high concentrations of the antiepileptic drugs caused apoptosis, mainly in the case of oxcarbazepine and carbamazepine, and the apoptotic pathway may involve the activation of caspase-3-like enzymes. It was previously shown that exposure of cultured cerebellar granule cells to carbamazepine for 3 Ž days induced apoptosis Gao and Chuang, 1992; Gao et al., . 1995; Nonaka et al., 1998 . Some antiepileptic drugs, including carbamazepine, were found to reduce glutamine Ž . synthetase activity in mouse brain Fraser et al., 1999 , and acute CNS side effects in healthy volunteers were also Ž . reported Noachtar et al., 1998 . Oxcarbazepine is a new antiepileptic drug that is almost clinically indistinguishable from carbamazepine, but which has some improved properties, as for example in terms of liver enzyme-inducing Ž . effects Elger and Bauer, 1998 . To our knowledge, there are no reports in the literature concerning toxic effects of this carbamazepine derivative in the CNS. Surprisingly, we observed that oxcarbazepine was more toxic than carbamazepine. The toxic effect of oxcarbazepine was more pronounced and was observed at lower concentrations.
It is well established that excessive activation of ionotropic glutamate receptors causes neurodegeneration. However, NMDA or AMPA receptors were not involved in the neurotoxic effect caused by high concentrations of carbamazepine, since the toxic effect was not prevented by NMDA or AMPA receptor antagonists.
BIA 2-093 was found to be as potent as carbamazepine, and more potent than oxcarbazepine, in preventing maximal electroshock-induced seizures, when the compounds were given by gastric tube. Both BIA 2-093, carbamazepine and oxcarbazepine caused a dose-dependent motor impairment in rats. When the compounds were given by intraperitoneal route, the protective index for BIA 2-093 was greater than the protective index for carba-Ž . mazepine and oxcarbazepine Benes et al., 1999a . Thus, these results, together with our findings, suggest that BIA 2-093 or BIA 2-024 may have some advantages as compared to carbamazepine or oxcarbazepine.
Toxicity induced by kainate, Õeratridine or ischaemia-like conditions: lack of protection by BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine
Glutamate is involved in the initiation of seizures and their propagation, and some evidence indicates potential Ž roles for both NMDA and non-NMDA receptors Loscher, . 1998b . Moreover, kainic acid seizure models are widely used to evaluate the efficacy of antiepileptic agents. Taking this into account, we investigated whether BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine, at concentra-( )tions that did not cause toxicity, could have a neuroprotective effect on kainate-induced toxicity in hippocampal neurons, which is essentially mediated by the activation of Ž . AMPA receptors Ambrosio et al., 2000 . The results shoẃ that the antiepileptic drugs did not protect hippocampal neurons from the toxicity caused by kainate.
Contrary to our results, it was previously reported that carbamazepine afforded significant protection against glu-Ž tamate neurotoxicity in hippocampal cell cultures Mattson . and Kater, 1989; Mark et al., 1995 , and Grant et al. 1992 showed that the inhibition caused by carbamazepine of NMDA-induced responses appeared to be independent of the NMDA recognition site. These findings suggest that blockade of ionotropic glutamate receptors is not the mechanism by which carbamazepine exerted protective effects in other systems.
Since BIA 2-093, BIA 2-024, carbamazepine or oxcar-Ž bazepine inhibit voltage-sensitive sodium channels McLean et al., 1994; Kuo et al., 1997; Benes et al., 1999a;  . unpublished observations , we investigated whether these antiepileptic drugs could be neuroprotective against veratridine-induced toxicity. The results showed that the antiepileptic drugs did not protect hippocampal neurons from veratridine-induced toxicity. Probably, the concentrations of the antiepileptic drugs were not high enough to inhibit the effect of veratridine. However, it was previously reported that some antiepileptic drugs, including carbamazepine, protected rat cortical cultures against 100 Ž . mM veratridine-induced cell death Lakics et al., 1995 . In addition, these authors suggested that mechanisms other than sodium channel blockade may be involved in the neuroprotection.
There is now substantial evidence from animal models that sodium channel blockers prevent neuronal damage Ž . caused by global and focal brain ischaemia Taylor, 1996 . Ž . We used an ischaemic-like insult chemical ischaemia in order to evaluate whether BIA 2-093, BIA 2-024, carbamazepine or oxcarbazepine has a neuroprotective effect in hippocampal neurons. The effect of 2-deoxyglucose and cyanide was synergistic, because exposure of hippocampal neurons to either deoxyglucose or cyanide alone caused only a small toxic effect. The presence of the antiepileptic drugs, during and after the ischaemia-like insult, did not protect hippocampal neurons. Conversely, in vivo studies have demonstrated that some antiepileptic drugs, including carbamazepine, reduce cerebral damage after focal is-Ž chaemia in rodents Rataud et al., 1994; Minato et al., . 1997 , pointing to a therapeutic potential for voltage-dependent sodium channel blockers. Such compounds may act at sodium channels to prevent depolarisation, inhibiting the release of neurotransmitters such as glutamate and thus Ž . protecting the brain. Minato et al. 1997 also showed that carbamazepine ameliorated the effects of brain infarction and improved neurological deficits, but only above the anticonvulsant dose. Contrary to this observation, it was also shown that carbamazepine protected the rat optic nerve against anoxic injury at concentrations well below Ž . those used clinically to treat epilepsy Fern et al., 1993 . Taken together, our results showed that the antiepileptic drugs tested may be toxic to cultured hippocampal neurons, at least at high concentrations, and that the toxic effect is also observed as apoptosis. However, the new putative antiepileptic drugs, BIA 2-093 and BIA 2-024, were less toxic than carbamazepine or oxcarbazepine, with oxcarbazepine being the most toxic. The activation of NMDA or AMPA receptors did not contribute to the toxic effect caused by carbamazepine. In addition, these antiepileptic drugs failed to protect hippocampal neurons against different toxic insults: kainate or veratridine exposure, and ischaemia-like conditions. However, previous findings for other systems, indicate that antiepileptic drugs, under some conditions, can be neuroprotective.
